D. Gasi Tandefelt

ETS fusion genes in prostate cancer.

J. Trapman, J. Boormans, D. Gasi Tandefelt, 2014, Endocrine-related cancer.

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

D. Amadori, D. Dearnaley, M. Climent, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Circulating cell-free DNA: Translating prostate cancer genomics into clinical care.

D. Gasi Tandefelt, J. D. de Bono, Delila Gasi Tandefelt, 2020, Molecular aspects of medicine.

A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers.

G. Jenster, J. Trapman, J. Boormans, 2013, European urology.

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration

N. Tunariu, U. Banerji, C. Leux, 2015, Clinical Cancer Research.